Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,019 | 232 | 79.8% |
| Consulting Fee | $1,200 | 1 | 15.9% |
| Travel and Lodging | $293.16 | 1 | 3.9% |
| Education | $26.37 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $1,905 | 7 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,885 | 95 | $0 (2024) |
| Amgen Inc. | $1,822 | 62 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $284.37 | 15 | $0 (2024) |
| GlaxoSmithKline, LLC. | $136.66 | 8 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $132.86 | 4 | $0 (2020) |
| Medtronic Vascular, Inc. | $124.20 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $120.00 | 1 | $0 (2019) |
| AbbVie Inc. | $112.68 | 5 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $102.86 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $121.73 | 6 | AstraZeneca Pharmaceuticals LP ($36.43) |
| 2023 | $482.89 | 24 | AstraZeneca Pharmaceuticals LP ($208.11) |
| 2022 | $2,270 | 26 | Biohaven Pharmaceutical Holding Company Ltd. ($1,905) |
| 2021 | $961.43 | 46 | Amgen Inc. ($369.39) |
| 2020 | $804.37 | 41 | AstraZeneca Pharmaceuticals LP ($321.50) |
| 2019 | $1,030 | 34 | AstraZeneca Pharmaceuticals LP ($359.41) |
| 2018 | $778.33 | 28 | Amgen Inc. ($344.22) |
| 2017 | $1,090 | 31 | Amgen Inc. ($318.92) |
All Payment Transactions
236 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.82 | General |
| 05/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Inflammation | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/07/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $23.19 | General |
| Category: Allergy/Immunology | ||||||
| 04/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Inflammation | ||||||
| 01/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Respiratory | ||||||
| 11/28/2023 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $23.59 | General |
| Category: Allergy/Immunology | ||||||
| 11/16/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Diabetes | ||||||
| 11/14/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Inflammation | ||||||
| 10/26/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $120.39 | General |
| Category: Cardiology | ||||||
| 09/21/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $4.15 | General |
| Category: Inflammation | ||||||
| 09/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/20/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.20 | General |
| Category: Inflammation | ||||||
| 07/11/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/29/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Diabetes Care | ||||||
| 05/25/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $4.79 | General |
| Category: Inflammation | ||||||
| 04/03/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: Inflammation | ||||||
| 03/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $42.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/28/2023 | Hologic Sales and Service, LLC | APTIMA (Device), THINPREP 2000 PROCESSOR | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Diagnostics | ||||||
| 02/28/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: Inflammation | ||||||
| 02/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 348 | 701 | $252,991 | $58,407 |
| 2022 | 8 | 262 | 508 | $191,468 | $45,633 |
| 2021 | 9 | 323 | 540 | $194,298 | $52,753 |
| 2020 | 10 | 423 | 655 | $127,649 | $47,368 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 344 | $149,296 | $31,725 | 21.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 53 | 53 | $36,782 | $7,064 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 113 | $28,815 | $6,848 | 23.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 20 | 23 | $12,811 | $5,255 | 41.0% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 27 | 27 | $14,534 | $4,894 | 33.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $3,467 | $1,083 | 31.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 40 | 40 | $3,040 | $876.00 | 28.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 14 | 14 | $2,338 | $472.57 | 20.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 12 | $348.00 | $143.76 | 41.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 41 | $1,560 | $44.48 | 2.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 272 | $117,871 | $24,474 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 89 | $23,567 | $5,213 | 22.1% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 26 | 26 | $14,534 | $5,209 | 35.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 15 | 22 | $12,254 | $4,918 | 40.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 32 | 32 | $7,808 | $2,193 | 28.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 12 | 12 | $8,328 | $1,628 | 19.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 33 | 33 | $3,432 | $1,022 | 29.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 19 | 22 | $3,674 | $976.72 | 26.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 225 | $96,508 | $21,105 | 21.9% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 50 minutes | Office | 2021 | 47 | 58 | $32,422 | $13,303 | 41.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 103 | $23,919 | $6,463 | 27.0% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 12 | 14 | $7,571 | $3,202 | 42.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 42 | 42 | $10,248 | $2,741 | 26.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 15 | 18 | $6,804 | $2,180 | 32.0% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 32 | 32 | $5,344 | $1,567 | 29.3% |
About Dr. Rupal Shah, MD
Dr. Rupal Shah, MD is a Family Medicine healthcare provider based in Corona, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1396730560.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rupal Shah, MD has received a total of $7,539 in payments from pharmaceutical and medical device companies, with $121.73 received in 2024. These payments were reported across 236 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,019).
As a Medicare-enrolled provider, Shah has provided services to 1,356 Medicare beneficiaries, totaling 2,404 services with total Medicare billing of $204,160. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Corona, CA
- Active Since 09/14/2005
- Last Updated 06/15/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396730560
Products in Payments
- NURTEC ODT (Drug) $1,905
- FARXIGA (Drug) $1,823
- Aimovig (Biological) $751.86
- Repatha (Biological) $442.00
- Prolia (Biological) $209.84
- Otezla (Drug) $155.11
- EVENITY (Biological) $140.14
- JARDIANCE (Drug) $137.50
- UBRELVY (Drug) $126.12
- Micra (Device) $124.20
- Epclusa (Drug) $120.00
- APTIOM (Drug) $102.86
- Kerendia (Drug) $102.74
- UPTRAVI (Drug) $98.80
- INSPIRIS RESILIA aortic valve (Device) $95.89
- XARELTO (Drug) $94.68
- STIOLTO RESPIMAT (Drug) $93.66
- SHINGRIX (Biological) $53.41
- ImmunoCAP (Device) $46.78
- SYMBICORT (Drug) $43.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Corona
Mrs. Kimberly Minesinger, D.o, D.O
Family Medicine — Payments: $7,837
Tanya Nanayakkara, M.d, M.D
Family Medicine — Payments: $7,069
Mrs. Smita Lodha, Md, MD
Family Medicine — Payments: $4,474
Dr. Michael Baluyut, Md, MD
Family Medicine — Payments: $3,870
Anuradha Sathya, Md, MD
Family Medicine — Payments: $2,696
Zachary Valadez, M.d, M.D
Family Medicine — Payments: $2,633